This post was originally published on this site
Microsoft (NASDAQ:MSFT) is said to be in discussions to invest up to $10 billion in OpenAI, the creator of the ChatGPT platform, according to a report by Semafor. The funding round will also include other venture capital firms, and values OpenAI at around $29 billion.
As part of the deal, Microsoft will reportedly take in 75% of OpenAI’s profits until the initial investment is recouped. After that point, Microsoft will hold a 49% stake in OpenAI, while other investors will also hold a 49% stake, and OpenAI’s nonprofit parent will hold a 2% stake.
The report comes amid speculation that Microsoft is planning to incorporate OpenAI’s technology into its Office and email software products. According to previous reports, Microsoft had invested around $1 billion in cash and cloud credits into OpenAI in 2019, and has been considering increasing its investment in the company.
Microsoft shares rose 5.5% for the week.
CinCor Pharma (NASDAQ:CINC) rocketed some 150% after AstraZeneca (NASDAQ:AZN) agreed to buy out the company for $26 per share, or $1.3 billion, a 121% premium over CinCor’s most recent close. The deal also includes a contingent value right of $10 per share in cash, or $500 million, “payable upon a specified regulatory submission of a baxdrostat product.” CinCor closed the week at $28.95.
Amryt (NASDAQ:AMYT) shares soared 107% after Chiesi Farmaceutici agreed to buy the Ireland-based biopharma for $14.50 per American depositary share (ADS), or $1.25 billion in cash, plus contingent value rights worth up to another $2.50 per ADS – or $225 million – if certain milestones are achieved. Amryt ended the week at $14.72.
Oak Street Health (NYSE:OSH) shares gained more than 27% last Monday after Bloomberg News reported that CVS Health (NYSE:CVS) is in advanced talks to acquire the company and is prepared to pay more than $10 billion to close the deal in the coming weeks.
Also on Monday, Duck Creek Technologies (NASDAQ:DCT) shares surged more than 46% after the company announced it has agreed to be acquired by Vista Equity Partners for $19.00 per share in an all-cash transaction valued at approximately $2.6 billion.
And in that same session, Paya Holdings (NASDAQ:PAYA) shares gained more than 24% on news it had agreed to be purchased by Nuvei (NASDAQ:NVEI) in an all-cash transaction at $9.75 per share, or some $1.3 billion.
***
If you’re interested in upgrading your search for new investing ideas, check out InvestingPro.
